Legal Opinion
Ignacuinos v. Boehringer Ingelheim Pharms.
Court of Appeals for the Second Circuit
Decided August 6, 2021No. 20-3643-cvPublishedCited by 4 opinions
1Opinion of the Court
20-3643-cv Ignacuinos v. Boehringer Ingelheim Pharms. 1 UNITED STATES COURT OF APPEALS 2 FOR THE SECOND CIRCUIT 3 4 August Term, 2020 5 6 (Submitted: April 30, 2021 Decided: August 6, 2021) 7 8 Docket No. 20-3643 9 10 _____________________________________ 11 12 CARL IGNACUINOS, ON BEHALF OF HIMSELF AND OTHERS 13 SIMILARLY SITUATED, PAMELA DAVIS, ON BEHALF OF 14 HERSELF AND OTHERS SIMILARLY SITUATED, 15 16 Plaintiffs-Appellants, 17 18 v. 19 20 BOEHRINGER INGELHEIM PHARMACEUTICALS INC, 21 22 Defendant-Appellee. * 23 _____________________________________ 24 25 Before: 26 27 LOHIER and BIANCO,…
2Cases cited8 opinions
- Wyeth v. LevineSupreme Court of the United States · 2009
- Dolan v. ConnollyCourt of Appeals for the Second Circuit · 2015
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
- Gibbons v. Bristol-Myers Squibb Co.Court of Appeals for the Second Circuit · 2019
- Mut. Pharm. Co. v. BartlettSupreme Court of the United States · 2013
3 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Alvarado v. PBM, LLCDistrict Court, D. Connecticut · 2022
- Herlth v. Merck & Co IncDistrict Court, D. Connecticut · 2022
- Polson v. AstraZeneca LPDistrict Court, D. Connecticut · 2023
- Timothy J. Golden v. Verizon New York, Inc.District Court, E.D. New York · 2026